Terms: = Kidney tumors AND ERBB2, c-erb B2, 2064, P04626, ENSG00000141736, c-erbB2, HER-2/neu, HER2, TKR1, NEU, NGL, HER-2 AND Staging
5 results:
1. Gene mutation profiling and clinical significances in patients with renal cell carcinoma.
Wang Y; He P; Zhou X; Wang C; Fu J; Zhang D; Liao D; Zhou Z; Wu C; Gong W
Clinics (Sao Paulo); 2023; 78():100259. PubMed ID: 37515929
[TBL] [Abstract] [Full Text] [Related]
2. Synchronous tumors: Adenocarcinoma of the Esophagus and Clear Cell Renal Carcinoma.
Narra RK; Alvarez Argote J; Mesologites T; Dasanu CA
Conn Med; 2015 Aug; 79(7):401-4. PubMed ID: 26411176
[TBL] [Abstract] [Full Text] [Related]
3. Human epidermal growth factor receptor 2 expression in urothelial carcinoma of the renal pelvis: correlation with clinicopathologic parameters.
Ehsani L; Osunkoya AO
Int J Clin Exp Pathol; 2014; 7(5):2544-50. PubMed ID: 24966967
[TBL] [Abstract] [Full Text] [Related]
4. Frequency and clinicopathologic correlates of ErbB1, erbb2, and ErbB3 immunoreactivity in urothelial tumors of upper urinary tract.
Tsai YS; Tzai TS; Chow NH; Wu CL
Urology; 2005 Dec; 66(6):1197-202. PubMed ID: 16360440
[TBL] [Abstract] [Full Text] [Related]
5. her-2/neu is expressed in human renal cell carcinoma at heterogeneous levels independently of tumor grading and staging and can be recognized by HLA-A2.1-restricted cytotoxic T lymphocytes.
Seliger B; Rongcun Y; Atkins D; Hammers S; Huber C; Störkel S; Kiessling R
Int J Cancer; 2000 Aug; 87(3):349-59. PubMed ID: 10897039
[TBL] [Abstract] [Full Text] [Related]
